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Deficiency of S6 kinase (S6K) extends the lifespan
of multiple species, but the underlying mechanisms
are unclear. To discover potential effectors of S6K-
mediated longevity, we performed a proteomics anal-
ysis of long-lived rsks-1/S6K C. elegans mutants
compared towild-typeanimals.We identified theargi-
nine kinaseARGK-1as themost significantly enriched
protein in rsks-1/S6Kmutants. ARGK-1 is an ortholog
of mammalian creatine kinase, which maintains
cellular ATP levels. We found that argk-1 is possibly
a selective effector of rsks-1/S6K-mediated longevity
and that overexpression of ARGK-1 extends C. ele-
gans lifespan, in part by activating the energy sensor
AAK-2/AMPK. argk-1 is also required for the reduced
bodysizeand increasedstress resistanceobserved in
rsks-1/S6Kmutants. Finally, creatine kinase levels are
increased in the brains of S6K1 knockout mice. Our
study identifies ARGK-1 as a longevity effector in
C. elegans with reduced RSKS-1/S6K levels.INTRODUCTION
The TOR pathway plays a conserved role in organismal aging, in
part by regulating mRNA translation through S6 kinase (S6K). In-
hibition of either TOR or S6K reduces the rate of protein synthe-
sis and extends the lifespan of organisms ranging from yeast to
mice. Animals with decreased S6K activity also have reduced
body and brood sizes (Kapahi et al., 2010). However, the nature
of the S6K effectors regulating these phenotypes and the mech-
anisms by which they contribute to the long lifespan of S6K
mutants remain elusive.
In the nematode C. elegans, reduced levels of S6K (called
RSKS-1) reduces translation rates, delays development, de-Cecreases body and brood sizes, and promotes stress resistance
and longevity (Hansen et al., 2007; Korta et al., 2012; Pan et al.,
2007; Selman et al., 2009). A number of proteins have been re-
ported to function downstream of RSKS-1/S6K in lifespan deter-
mination: the transcription factors PHA-4/FOXA (Sheaffer et al.,
2008), HIF-1 (Chen et al., 2009), HSF-1 (Seo et al., 2013), and
HLH-30/TFEB (Lapierre et al., 2013); the autophagy protein
ATG-18/WIPI (Lapierre et al., 2013); and AAK-2, the catalytic a
subunit of AMP-activated protein kinase (AMPK) (Selman et al.,
2009). However, all of these factors play roles in additional
C. elegans longevity paradigms, and effectors selective for the
S6K pathway have yet to be identified and investigated.
AMPK is the principal energy sensor in eukaryotes and is
thus critical for the maintenance of cellular energy homeostasis
(Hardie et al., 2012). AMPK functions as a heterotrimer con-
sisting of catalytic a, regulatory g, and scaffolding b subunits.
In response to low energy status, AMPK is activated via phos-
phorylation and restores homeostasis by activating a number of
energy-conserving pathways (Hardie et al., 2012). C. elegans
AAK-2/AMPK also functions as an energy sensor (Apfeld
et al., 2004) and plays an important role in several longevity
paradigms in addition to S6K reduction, including impaired
insulin/IGF-1 signaling (Apfeld et al., 2004) and certain forms
of dietary restriction (Greer et al., 2007). Although AMPK is acti-
vated in response to S6K deficiency in mice and worms (Aguilar
et al., 2007; Selman et al., 2009), the mechanism linking these
kinases is unclear.
In this study, we sought to discover downstream targets of
S6K with potential roles in longevity. We used two-dimensional
liquid chromatography-tandem mass spectrometry (2DLC-MS/
MS) for in-depth discovery and identification of proteins with
differential abundance in long-lived rsks-1/S6K mutants
compared with wild-type animals. From this proteomics data-
set, we identified arginine kinase ARGK-1/F44G3.2 as the
most significantly enriched in rsks-1/S6K mutants. Arginine ki-
nases are functionally equivalent to mammalian creatine ki-
nases, collectively referred to as phosphagen kinases, whichll Reports 14, 2059–2067, March 8, 2016 ª2016 The Authors 2059
act as intracellular energy buffers (Ellington, 2001). We show
that ARGK-1 plays a critical role in establishing specific pheno-
types of rsks-1/S6K mutants, as demonstrated by the require-
ment for argk-1 for the reduced body size, increased stress
resistance, increased AAK-2/AMPK activity, and extended life-
span of these mutants. ARGK-1 displayed a restricted expres-
sion pattern, including in a small subset of C. elegans glial cells.
Consistently, we observed increased levels of creatine kinase
in the brains of S6K1/ mice, suggesting conserved regulation
of phosphagen kinases in this longevity paradigm. Collectively,
we have identified the arginine kinase ARGK-1 as a selective
longevity effector of S6K in C. elegans, highlighting an impor-
tant role for cellular ATP homeostasis in this conserved
longevity model.
RESULTS
Proteomic Analysis Identifies the Arginine Kinase
ARGK-1 as a Putative S6K Effector
To search for downstream effectors of S6K, we used global pro-
teomic profiling of day-1 adult rsks-1(sv31) mutants and wild-
type animals (label-free quantification via spectral counting;
see Supplemental Experimental Procedures and Table S1 for
spectral counts). In this analysis, we observed 339 proteins
with spectral counts >1.8-fold more or less abundant in
rsks-1(sv31) mutants compared to wild-type animals (p < 0.05
using a moderate t test and Welch test). Of these, 139 proteins
were putatively increased (Table S2) and 200 proteins were pu-
tatively decreased (Table S3) in rsks-1/S6K mutants. Of partic-
ular note, the list of proteins more abundant in rsks-1/S6K
mutants contained several cytochrome P450s, UGTs, and
GSTs, consistent with a role for S6K in the detoxification
response (Wang et al., 2010), as well as the autophagy protein
ATG-18/WIPI (Tables S1 and S2). Using a new translational
ATG-18::GFP reporter, we confirmed that rsks-1/S6K animals
had increased ATG-18/WIPI levels (Figure S1A), which is consis-
tent with atg-18/WIPI being required for rsks-1/S6K-mediated
lifespan extension (Lapierre et al., 2013). However, the majority
of the differentially abundant proteins identified have not previ-
ously been linked to rsks-1/S6K. Of particular note, GO analysis
suggested that a large number of proteins predicted to be asso-
ciated with biosynthesis of nucleobase-containing compounds
were more abundant in rsks-1/S6K mutants compared to wild-
type animals (Table S2).
Themost differentially abundant protein in rsks-1/S6Kmutants
was ARGK-1/F44G3.2, one of five C. elegans arginine kinases
(Fraga et al., 2015). ARGK-1 showed a >35-fold increase in spec-
tral count ratio (Table S2), which arose mainly from undetectable
spectral counts in wild-type animals (Table S1). In contrast, wild-
type and rsks-1(sv31) animals showed comparable argk-1 (and
atg-18/WIPI) mRNA levels (Figure S1B), suggesting that argk-1
(and atg-18/WIPI) may be subject to post-transcriptional regula-
tion in rsks-1/S6K mutants. Arginine kinases are members of
the phosphagen kinase family and function to maintain intracel-
lular ATP levels by catalyzing the reversible reaction: ATP + argi-
nine! ADP + phospho-arginine (Ellington, 2001). Due to its role
in energy regulation, we focused the rest of our study on inves-
tigating ARGK-1 as a candidate S6K effector.2060 Cell Reports 14, 2059–2067, March 8, 2016 ª2016 The Authorsargk-1 Is Required for Body Size, Thermotolerance, and
Longevity of rsks-1/S6K Mutants
rsks-1/S6K mutants have previously been shown to have
reduced body and brood sizes, increased resistance to environ-
mental stressors, as well as an extended lifespan (Hansen et al.,
2007; Korta et al., 2012; Pan et al., 2007; Wang et al., 2010). To
investigate whether argk-1 contributes to these phenotypes,
we introduced two predicted argk-1 null alleles (ok2993 and
ok2973), respectively, into the rsks-1(sv31) mutant. Wild-type
animals carrying either of these two alleles behaved similarly
and displayed no obvious phenotypes (Figure S2A; data not
shown). Whereas rsks-1/S6K mutants are smaller than wild-
type animals (Hansen et al., 2007; Pan et al., 2007; Seo et al.,
2013), rsks-1; argk-1 double mutants were similar in size to
wild-type animals (Figure S2A; day-1 adults). In contrast,
rsks-1; argk-1 double mutants displayed reduced brood size
(Figure S2B) and developmental delay (data not shown) similar
to rsks-1 mutants. Similarly, we observed a partial requirement
for argk-1 in rsks-1/S6K-mediated thermotolerance (Table S3).
Collectively, our findings suggest an important role for argk-1
in rsks-1/S6Kmutants in determining body size and thermotoler-
ance, but not progeny production and developmental timing,
thus dissociating these phenotypes.
We next compared the lifespans of rsks-1 and rsks-1; argk-1
double mutants. Whereas rsks-1(sv31) single mutants were
considerably longer lived than wild-type animals (Hansen
et al., 2007), the presence of either of the two argk-1 deletion
alleles abolished this lifespan extension (Figure 1A; Table S4).
Similarly, the lifespan of rsks-1(sv31) animals fed bacteria ex-
pressing argk-1 dsRNA (i.e., subjected to argk-1 RNAi) during
adulthood was comparable to that of wild-type animals (Fig-
ure 1B; Table S4). Notably, argk-1 deletion alleles or argk-1
adult-only RNAi had no significant effects on the lifespan of
wild-type animals (Table S4). These observations indicate an
important role for argk-1 in rsks-1/S6K-mediated lifespan
extension. We next asked whether argk-1 plays a role in other
conserved longevity paradigms, i.e., reduced insulin/IGF-1
signaling (e.g., the insulin/IGF-1 receptor mutant daf-2; Kenyon
et al., 1993), dietary restriction (e.g., the feeding-impaired
mutant eat-2; Lakowski and Hekimi, 1998), and reduced mito-
chondrial respiration (e.g., the ubiquinone synthesis mutant
clk-1; Felkai et al., 1999). In three independent trials, we found
that argk-1 RNAi had no significant effect on the lifespans of
these long-lived mutants (Figures 1C and 1E; Table S4), and
daf-2; argk-1 and eat-2; argk-1 double mutants had compara-
ble lifespans to daf-2 and eat-2 single mutants, respectively
(Table S4). Thus, argk-1 is possibly a selective longevity
effector in rsks-1/S6K animals.
argk-1 Is Required for Activation of AAK-2/AMPK in
rsks-1/S6K Mutants
Given that phosphagen kinases play central roles in buffering
intracellular energy levels, we considered whether argk-1 might
function together with the known rsks-1/S6K longevity effector,
AMPK. This energy-sensing kinase is functionally conserved in
C. elegans (Apfeld et al., 2004), and the a-subunit aak-2/AMPK
is required for the long lifespan of rsks-1(ok1255) mutants (Sel-
man et al., 2009). Moreover, thesemutants have increased levels
Figure 1. argk-1 Is Selectively Required for the Long Lifespan of rsks-1/S6K Mutants
(A) Lifespan analysis of wild-type (WT; N2), argk-1(ok2993), rsks-1(sv31), and rsks-1(sv31); argk-1(ok2993) double mutants. Four replicate experiments and four
additional experiments assaying the argk-1(ok2973) allele were performed; see Table S4 for details and statistical analysis.
(B–E) Lifespan analysis of WT, rsks-1(sv31) (B), insulin/IGF-1 receptor daf-2(e1370) (C), dietary-restricted eat-2(ad1116) (D), and mitochondrial clk-1(e2519)
animals (E) fed bacteria expressing control or argk-1 dsRNA from day 1 of adulthood. Three replicate experiments were performed, as well as analysis of daf-2;
argk-1 and eat-2; argk-1 double mutants; see Table S4. All lifespan experiments were performed at 20C.of phosphorylated (active) AAK-2/AMPK (Selman et al., 2009;
Chen et al., 2013). We therefore examined the effects of argk-1
deletion on AAK-2/AMPK phosphorylation in rsks-1(sv31) mu-
tants. Indeed, levels of phosphorylated AAK-2/AMPK were
significantly reduced in rsks-1; argk-1 double mutants compared
to rsks-1 single mutants and were similar to the levels in wild-
type animals and argk-1 single mutants (Figures 2A and 2B).CeWe cannot exclude the possibility that the observed increase
in phosphorylated AAK-2/AMPK levels in rsks-1(sv31) mutants
could reflect a change in total AAK-2/AMPK protein levels. How-
ever, our proteomic dataset revealed no significant difference in
the relative abundance of AAK-2/AMPK spectral count ratios in
rsks-1/S6K compared to wild-type animals (Table S1), arguing
against such an explanation.ll Reports 14, 2059–2067, March 8, 2016 ª2016 The Authors 2061
Figure 2. argk-1 Is Required for Increased
AMPK Activity in rsks-1/S6K Mutants
(A)PhosphorylationofAMP-activatedkinase (AMPK)
was assessed in wild-type (WT; N2), rsks-1(sv31),
argk-1(ok2993), and rsks-1(sv31); argk-1(ok2993)
animals by western blotting using an antibody
against mammalian phospho-AMPKa Thr 172.
b-actin was used as a loading control.
(B) Quantification of the phospho-AMPK signal
(normalized to the loading control) averaged from
three independent western blots (as in A). Error
bars are SEM. *p < 0.05; ***p < 0.001 by one-way
ANOVA.
(C) Phosphorylation of acetyl-CoA carboxylase
(ACC) was assessed in the strains indicated in (A)
by western blotting using an antibody against
mammalian phospho-ACC Ser 59. b-actin was
used as a loading control. The band at 200 kDa
is likely to be POD-2/ACC (see Supplemental
Experimental Procedures).
(D) Quantification of the phospho-ACC signal
(normalized to the loading control) averaged from
three independent western blots (as in C). Error
bars are SEM. *p < 0.05; **p < 0.01; ***p < 0.001 by
one-way ANOVA. All lysates were from day-1
adults raised at 20C.To further investigate the role of ARGK-1 in rsks-1/S6K-medi-
ated AAK-2/AMPK activation, we examined phosphorylation
of acetyl-CoA carboxylase (ACC), an enzyme that is important
for the biosynthesis and oxidation of fatty acids and is
regulated by AMPK-mediated phosphorylation (Hardie et al.,
2012). We observed a robust (18-fold) increase in the
abundance of a 200-kD band, likely corresponding to phos-
phorylated POD-2/ACC, in rsks-1(sv31) mutants compared to
either wild-type or argk-1(ok2993) animals (Figures 2C and
2D). In contrast, rsks-1; argk-1 double mutants showed a partial
induction of ACC phosphorylation (Figures 2C and 2D). Here
too, we note the possibility that the differences in phosphory-
lated ACC levels may reflect differences in the levels of ACC
total protein. In this case, however, we were unable to address
this further because we did not detect POD-2/ACC in our pro-
teomic analysis.
Taken together, these analyses suggest that ARGK-1 is impor-
tant for full activation of AAK-2/AMPK, suggesting that the two
enzymes may function together in rsks-1/S6K animals.
ARGK-1 Overexpression Extends the Lifespan of Wild-
Type C. elegans
Because we found ARGK-1 levels to be increased in rsks-1(sv31)
mutants in our proteomic analysis, we reasoned that exoge-
nously driven overexpression of ARGK-1 might be sufficient
to induce at least some of the phenotypes observed in
rsks-1/S6K mutants. To investigate this hypothesis, we created
transgenic animals containing extrachromosomal arrays over-
expressing argk-1 fused to gfp from the ubiquitous promoter
of sur-5, an acetyl-CoA synthetase (sur-5p::argk-1::gfp). These2062 Cell Reports 14, 2059–2067, March 8, 2016 ª2016 The Authorsanimals expressed a GFP-tagged protein of 72 kD, the ex-
pected size for ARGK-1::GFP (data not shown). Interestingly,
we found that sur-5p::argk-1::gfp-overexpressing animals (two
independent lines, as well as an integrated strain) lived up to
25% longer than wild-type animals at both 20C and 25C (Fig-
ures 3A and 3B; Table S5). Importantly, the lifespan extension
conferred separately by ARGK-1 overexpression and rsks-1/
S6K deficiency was not additive, because rsks-1(sv31) animals
expressing sur-5p::argk-1::gfp were no longer lived than the
rsks-1(sv31) single mutants (Table S5). These observations
are consistent with the interpretation that the longer lifespans
of rsks-1/S6K mutants and ARGK-1-overexpressing animals
are mediated by at least partially overlapping mechanisms. In
further support of this notion, we observed that the FOXA tran-
scription factor PHA-4 was required for the extended lifespans
of sur-5p::argk-1::gfp-overexpressing animals (Table S5), as it
is for rsks-1/S6K mutants (Sheaffer et al., 2008). Moreover,
we found aak-2/AMPK to be required for the long lifespan
sur-5p::argk-1::gfp animals (Figure 3B; Table S5), and phos-
phorylation of both AAK-2/AMPK and its downstream target
ACC was significantly increased in the sur-5p::argk-1::gfp
animals (Figures 3C and 3D), as observed in rsks-1/S6K
mutants (Figure 2). These observations suggest that increased
AAK-2/AMPK activity may contribute to the lifespan extension
observed in animals overexpressing ARGK-1.
As rsks-1/S6K mutants, animals ubiquitously overexpressing
ARGK-1 were smaller than wild-type animals (Figure S2C), yet
had normal brood sizes (Figure S2D) and showed no develop-
mental delay (data not shown), consistent with argk-1 deletion
not affecting these two phenotypes in rsks-1/S6K mutants
Figure 3. aak-2/AMPK Contributes to Life-
span Extension by Overexpression of
ARGK-1
(A) Lifespan analysis of transgenic animals over-
expressing argk-1 from the ubiquitous sur-5
promoter (sur-5p::argk-1::gfp) and their non-
transgenic siblings (WT) at 25C. p < 0.0001; log
rank test. Nine replicate experiments of two inde-
pendent lines were performed at 20C and 25C;
see Table S5 for details.
(B) Lifespan analysis of WT or aak-2(ok524)
animals and their transgenic siblings expressing
sur-5p::argk-1::gfp at 20C. Four replicate ex-
periments were performed at 20C or 25C; see
Table S5.
(C) Phosphorylation of AMPK and ACC was
assessed in transgenic animals expressing
sur-5p::argk-1::gfp and non-transgenic siblings
(WT). b-actin was used as a loading control.
(D) Quantification of phospho-AMPK (left) and
phospho-ACC (right) signals (normalized to the
loading control) averaged from three independent
western blots (as in C). Error bars are SEM. *p <
0.05 by one-way ANOVA. All lysates were from
day-1 adults raised at 20C.
(E) Expression pattern of ARGK-1 in the head re-
gion of day-1 adult C. elegans expressing
mCherry-tagged ARGK-1 from a 1.1-kb endoge-
nous promoter (argk-1p::argk-1::mCherry). A re-
porter for the potassium-chloride cotransporter
KCC-3 tagged with GFP was used to aid in cell
identification. The merged panel shows partial
overlap of the ARGK-1::mCherry and KCC-3::GFP
signals. See also Figure S3F for co-localization
with an itx-1p::gfp reporter. The pharyngeal bulb is
visible in the differential interference contrast (DIC)
image. The scale bar represents 50 mm.(Figures S2A and S2B; data not shown). Unexpectedly, these
transgenic animals also displayed a small reduction in pharyn-
geal pumping rates (Figure S3A), a phenotype not observed in
adult rsks-1/S6K animals (Pan et al., 2007; data not shown).
However, the transgenic animals were not food deprived
because their food intake was comparable to that of wild-type
animals, as measured by a recently described spectrophoto-
metric assay (Gomez-Amaro et al., 2015; Figure S3B). Thus,
the long lifespan and small body size observed in rsks-1/S6K
mutants were recapitulated in animals ubiquitously overexpress-
ing ARGK-1, which, despite a small decrease in pharyngeal
pumping, appeared to have normal food intake and brood size.
Collectively, our analyses indicate a correlation between
increased levels of ARGK-1, reduced body size, AAK-2/AMPK
activation, and longer lifespan. We propose that ARGK-1 is a
critical regulator of these phenotypes in rsks-1/S6K mutants.
ARGK-1 Is Expressed in a Subset of Glial Cells in
C. elegans
We also constructed and analyzed lines expressing argk-1
tagged with mCherry from an endogenous promoterCe(argk-1p::argk-1::mCherry). Similar to our findings in animals ex-
pressing argk-1 from a ubiquitous promoter, we found that two
independent lines of argk-1p::argk-1::mCherry-overexpressing
animals lived longer (Table S5), were smaller (Figure S2C), had
normal brood sizes (Figure S2D), and showed a small reduction
in pharyngeal pumping rates (Figure S3C) compared to wild-type
animals. In contrast to sur-5p::argk-1::gfp transgenics, however,
argk-1p::argk-1::mCherry-overexpressing animals had signifi-
cantly reduced food intake (Figure S3D). We do not know why
ARGK-1 overexpression affects pumping rates in C. elegans
and results in reduced food intake in argk-1p::argk-1::mCherry-
overexpressing animals.Regardless,we cannot exclude thepos-
sibility that the extended lifespan of argk-1p::argk-1::mCherry-
overexpressing animals may be due to a form of dietary restric-
tion, andwe therefore refrain fromdrawing conclusions regarding
the lifespan analysis of these animals.
We next analyzed these transgenic animals to learn more
about the expression pattern of ARGK-1. Using confocal micro-
scopy, we detected weak ARGK-1 expression in a small number
of cells located mainly in the head and tail but predominantly
close to the anterior pharyngeal bulb (Figure 3E; data not shown).ll Reports 14, 2059–2067, March 8, 2016 ª2016 The Authors 2063
Figure 4. Creatine Kinase Expression Is Increased in the Cerebel-
lums of S6K/ Mice
(A) Levels of creatine kinase (CK-B; brain isoform), the mammalian homolog of
ARGK-1, were assessed in S6K1+/+ (n = 6) and S6K1/ (n = 5) mice cerebellar
tissue lysates. Males and females of age 5–8 weeks were analyzed.
(B) CK-B levels (normalized to GADPH) from (A) were quantified. Error bars
represent ±SEM. *p < 0.05; unpaired, two-tailed Student’s t-test.
See Figure S4 for measurements in hippocampus and skeletal muscle.This restricted expression pattern was consistent with essen-
tially undetectable numbers of ARGK-1 spectral counts in wild-
type animals (Table S1). To identify ARGK-1-expressing cells,
we examined double-transgenic animals also expressing GFP
fused to KCC-3, a sodium potassium chloride cotransporter
and marker for glial cells of C. elegans (Tanis et al., 2009). As in
other organisms, C. elegans glia surround and support neurons
and play important roles in their protection and nourishment
and possibly in intercellular signaling (Oikonomou and Shaham,
2011). We observed co-localization of ARGK-1 fluorescence in
several KCC-3-positive glia (Figure 3E), likely positioned in the in-
ner and outer labial sensilla next to sensory neurons connecting
to the outside environment because we observed overlap with
an itx-1p::gfp transcriptional reporter that highlights inner and
outer labial socket cells (Figure S3E; Haklai-Topper et al.,
2011). The overlap in ARGK-1 and KCC-3 expression was partic-
ularly interesting because mammalian KCC3 has been reported
to co-localize with creatine kinase, the mammalian ortholog of
ARGK-1, in cultured cells as well as in mouse brains (Salin-Can-
tegrel et al., 2008). We note that it is possible that ARGK-1 is
expressed at additional sites in C. elegans because animals car-
rying a transcriptional GFP reporter (argk-1p::gfp) showed
noticeable GFP signal in additional cells besides the inner and
outer labial socket cells, including in the intestine (Figure S3F).
Irrespectively, we conclude that ARGK-1 is expressed in glia in2064 Cell Reports 14, 2059–2067, March 8, 2016 ª2016 The AuthorsC. elegans, highlighting the possibility that ARGK-1 could play
a role in neuronal function.
Expression of Creatine Kinase Is Elevated in S6K1-
Deficient Mice
Mice deficient in S6K1, like C. elegans rsks-1/S6K mutants, are
longer lived than wild-type animals (Selman et al., 2009). To
address whether creatine kinase, the mammalian ortholog of
ARGK-1, is similarly regulated by S6K1, we examined a newly
created S6K1/ line (Figures S4A and S4C). Because we found
ARGK-1 to be expressed in glia in C. elegans, we examined cre-
atine kinase expression in the cerebellum of mice, an area of the
brain in which glial cells are known to participate in synaptic
transmission (Pfrieger, 2009). Extracts of cerebellums from
young (5–8 weeks old) S6K/ and S6K+/+ mice were subjected
to western blot analysis of creatine kinase isoform B, an isoform
of creatine kinase prominently expressed in the brain. Interest-
ingly, we found that creatine kinase isoform B levels were signif-
icantly increased in cerebellar extracts from both female and
male S6K1/ mice compared to wild-type animals (Figures 4A
and 4B). Whereas statistical significance was not reached,
trends toward elevated creatine kinase levels were also
observed in the hippocampus as well as in skeletal muscle
from S6K1/ mice compared to wild-type animals (Figures
S4D and S4E). These observations raise the possibility that,
like ARGK-1 in C. elegans rsks-1/S6K mutants, creatine kinase
may also be subject to regulation by S6K in mice.
DISCUSSION
Inhibition of S6K is a conserved longevity paradigm, but little is
known of the intermediary effectors that link the loss of S6K ac-
tivity with lifespan-extending pathways. Through a proteomic
analysis, we identified the arginine kinase ARGK-1 as a possibly
selective rsks-1/S6K longevity effector in C. elegans. ARGK-1
appears to act in concert with the energy sensor AMPK, another
rsks-1/S6K longevity effector, thus highlighting an important role
for energy regulation in this paradigm. Creatine kinases are the
mammalian functional orthologs of arginine kinases, and we
observed that creatine kinase expression is increased in the cer-
ebellums of S6K1/ mice, highlighting the possibility that S6K
may similarly regulate creatine kinases in higher organisms.
Our study provides direct evidence linking the protein family of
phosphagen kinases to longevity and to S6K. In support of this,
we observed (1) ARGK-1 to bemore abundant in rsks-1/S6Kmu-
tants than in wild-type animals (by spectral counts), (2) ubiqui-
tous overexpression of ARGK-1 is sufficient to extendC. elegans
lifespan, and (3) argk-1 is required for lifespan extension in
rsks-1/S6K mutants but is not required in other C. elegans
longevity paradigms tested. Whereas we have not been able
to confirm an increase in ARGK-1 levels in rsks-1/S6K mu-
tants, our observations collectively indicate that reduction of
RSKS-1/S6K engages ARGK-1 to extend C. elegans lifespan
and identify ARGK-1 as the first selective longevity effector of
RSKS-1/S6K. ARGK-1 is one of five arginine kinases in
C. elegans (Fraga et al., 2015), and five isoforms of creatine ki-
nase are expressed in different cell types in mammals. Although
none of these enzymes have previously been linked to longevity,
supplementation with creatine equivalent to arginine in meta-
zoans improves healthspan and longevity in mice and provides
beneficial effects to mice and potentially also to humans with
Parkinson’s disease (Matthews et al., 1999; Bender et al.,
2006, 2008; Hass et al., 2007). Moreover, we observed that cre-
atine kinase isoform B was significantly increased in the cere-
bellum of both female and male S6K1/ mice, yet only female
S6K1/mice are longer lived (Selman et al., 2009). Collectively,
these observations warrant further experiments to clarify the role
of arginine and creatine kinases in lifespan determination,
including in sex-specific contexts.
We found that argk-1 was also important for some, but not all,
of the phenotypes we examined in C. elegans rsks-1/S6K mu-
tants. Specifically, argk-1 was required, in addition to lifespan,
for the reduced body size and increased stress resistance, but
not for the reduction in progeny production and developmental
delay observed in rsks-1/S6K mutants. In turn, animals ubiqui-
tously overexpressing ARGK-1 were smaller and longer lived,
but these animals generally had normal brood sizes and devel-
opmental rates. Thus, we observed a correlation between small
body size, increased stress resistance, and longer lifespan but
no correlation to reduced progeny production or developmental
delay. It is possible that argk-1 exerts its physiological effects by
reversing the reduced mRNA translation rates observed in
rsks-1/S6K mutants (Hansen et al., 2007; Pan et al., 2007); how-
ever, because brood size or developmental rates, two verymeta-
bolically demanding outputs, were not significantly changed, this
may not be the case. Instead, ARGK-1 might be important for
regulation of the intracellular energy status of specific cells in
rsks-1/S6K mutants. In particular, we found ARGK-1 to be ex-
pressed in a small subset of glia adjacent to multiple sensory
neurons in the inner and outer labial sensilla. These neurons
connect to the outside environment, raising the interesting pos-
sibility that specific glia play a role in communicating with the
exterior to ensure the long lifespan of rsks-1/S6K mutants,
potentially via a circuit that also includes the intestine (because
a transcriptional argk-1 reporter also showed expression in
this tissue). In such a hypothetical scenario, ARGK-1 might
ensure adequate ATP levels for specific enzymes in ARGK-1-
expressing cells, as has been proposed for creatine kinase iso-
form B and KCC3 in mouse brains (Salin-Cantegrel et al.,
2008). Such ATP-dependent enzymes might be part of a
metabolic pathway important for the longevity observed in
rsks-1/S6K mutants. Identification of the proximal targets and
the site of action of ARGK-1 will be helpful in exploring the exact
mechanism by which RSKS-1/S6K modulates longevity via
ARGK-1 in C. elegans.
In support of a central role for ARGK-1 in energy regulation in
rsks-1/S6K mutants, we observed that argk-1 was both neces-
sary and sufficient to activate another known RSKS-1/S6K
longevity effector, AAK-2/AMPK. Consistent with a link between
these two energy-regulating systems, we found that aak-2/
AMPK was activated in and was required for the long lifespan
of animals ubiquitously overexpressing ARGK-1. These obser-
vations suggest a model in which reduced levels of RSKS-1/
S6K leads to induction of ARGK-1, which in turn is critical for
full activation of AMPK. Although AAK-2/AMPK is ubiquitously
expressed in C. elegans (Mair et al., 2011), it is not clear whetherCethe interaction between ARGK-1 and AMPK in rsks-1/S6K mu-
tants is direct or indirect. In this regard, it is interesting to note
that creatine kinase and AMPK can cross-regulate each other’s
activity in mammalian muscle cells (Ponticos et al., 1998).
Further experiments are needed to fully elucidate how ARGK-1
and AAK-2/AMPK act together to extend the lifespan of
C. elegans rsks-1/S6K mutants and whether a similar link is
conserved in S6K1-deficient mice.
In addition to ARGK-1, our proteomic analysis identified
138 other proteins that were putatively more abundant and
200 putatively less abundant in young rsks-1/S6K mutants
compared to wild-type animals. Whereas most of these pro-
teins have not previously been linked to rsks-1/S6K, many pro-
teins with roles in xenobiotic responses or in detoxification
were found to be more abundant, consistent with the observa-
tion that rsks-1/S6K mutants, similar to other translation mu-
tants, are more stress resistant than wild-type animals (Hansen
et al., 2007; Pan et al., 2007; Wang et al., 2010). Such transla-
tion mutants include C. elegans with reduced levels of the
translation initiation factor IFG-1/eIF4G, which achieves stress
resistance at least in part by mechanisms involving differential
mRNA translation (Rogers et al., 2011). Our study suggests
that similar regulatory mechanisms may exist in rsks-1/S6K
mutants, because we observed ARGK-1 and ATG-18/WIPI
proteins, but not their corresponding mRNA levels, to be
more abundant in rsks-1/S6K mutants compared to wild-type
animals. Future studies are needed to determine the exact
mechanism by which ARGK-1 and ATG-18/WIPI are regulated
in rsks-1/S6K mutants. Likewise, it will be interesting to
explore whether other differentially abundant proteins identi-
fied in our proteomic analysis, like ARGK-1, represent
longevity determinants.
In conclusion, our study reports the arginine kinase ARGK-1 to
be a selective effector relevant to the lifespan extension
observed in C. elegans rsks-1/S6K mutants. This mechanism
likely involves regulation of AMPK, highlighting an important
role for energy metabolism in this longevity paradigm. Future ex-
periments will reveal to which extent this longevity pathway plays
a conserved role in aging.
EXPERIMENTAL PROCEDURES
C. elegans Strains
C. elegans strains (Table S7) were maintained as described in Supplemental
Experimental Procedures. Two argk-1 mutant alleles were obtained from the
CGC and were outcrossed at least four times.
Lifespan Analysis
Lifespan analysis was carried out as previously described (Hansen et al.,
2005). Data were analyzed using STATA software (StataCorp), and p values
were calculated using the Mantel-Cox log rank test.
Western Blot Analysis
See Supplemental Experimental Procedures for details on preparation of
C. elegans and of mice samples and for immunoblotting with specific
antibodies.
Confocal Imaging
See Supplemental Experimental Procedures for details onmounting and imag-
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The accession number for the 2D LC-MS/MS raw data reported in this paper is
PeptideAtlas: PASS00820.
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Supplemental Information includes Supplemental Experimental Procedures,
four figures, and seven tables and can be found with this article online at
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